glabridin has been researched along with Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Y; Cheng, R; Guo, R; Hao, M; Li, J; Liang, Y; Shen, Z; Wang, H; Wang, J; Wang, S; Xu, W; Yang, Z; Yin, L; Yu, C; Zhai, Q; Zhang, J | 1 |
1 other study(ies) available for glabridin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Glabridin inhibits urothelial bladder carcinoma cell growth in vitro and in vivo by inducing cell apoptosis and cell cycle arrest.
Topics: Apoptosis; Carcinoma; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Urinary Bladder; Urinary Bladder Neoplasms | 2023 |